Caro made the remarks during a speech at the U.S. News & World Report Hospital of Tomorrow forum that took place in Washington, D.C. from Nov. 4 through 6, Northrop said Friday.
She told the event audience that Northrop is working with other companies and universities to help healthcare providers leverage technology intended to analyze, integrate, visualize and secure genetic information.
Caro also believes that genomics and proteomics could pave the way for improved disease diagnosis and
“Northrop Grumman’s focus on the role of information systems will accelerate the translation of genomic findings to clinical care, with the ultimate goal of helping this nation increase healthcare efficiency, reduce healthcare costs and improve health outcomes for its citizens,” she added.
She also said the new practices could lower costs through increasing preventative care, eliminating unnecessary treatment and reducing negative outcomes such as adverse drug reactions.